147 related articles for article (PubMed ID: 4093448)
21. The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections.
Vanassche T; Peetermans M; Van Aelst LN; Peetermans WE; Verhaegen J; Missiakas DM; Schneewind O; Hoylaerts MF; Verhamme P
J Infect Dis; 2013 Jul; 208(1):92-100. PubMed ID: 23532100
[TBL] [Abstract][Full Text] [Related]
22. Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin.
Kawabata S; Morita T; Iwanaga S; Igarashi H
J Biochem; 1985 Apr; 97(4):1073-8. PubMed ID: 4030715
[TBL] [Abstract][Full Text] [Related]
23. Human prothrombin activation.
Downing MR; Butkowski RJ; Clark MM; Mann KG
J Biol Chem; 1975 Dec; 250(23):8897-906. PubMed ID: 1238394
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the affinities to bovine and human prothrombin of the staphylocoagulases from Staphylococcus intermedius and Staphylococcus aureus of animal origin.
Raus J; Love DN
J Clin Microbiol; 1991 Mar; 29(3):570-2. PubMed ID: 2037675
[TBL] [Abstract][Full Text] [Related]
25. [Use of affinity chromatography for isolating prethrombin 1].
Strukova SM; Mitroshina TN; Umarova VA; Kudriashov BA
Vopr Med Khim; 1981; 27(6):840-4. PubMed ID: 7336661
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of activation of human prothrombin by an activator isolated from Dispholidus typus venom.
Guillin MC; Bezeaud A; Menache D
Biochim Biophys Acta; 1978 Nov; 537(1):160-8. PubMed ID: 102363
[TBL] [Abstract][Full Text] [Related]
27. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
[TBL] [Abstract][Full Text] [Related]
28. Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman.
Bodén MK; Flock JI
Microb Pathog; 1992 Apr; 12(4):289-98. PubMed ID: 1630299
[TBL] [Abstract][Full Text] [Related]
29. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.
Owen WG; Esmon CT; Jackson CM
J Biol Chem; 1974 Jan; 249(2):594-605. PubMed ID: 4809530
[No Abstract] [Full Text] [Related]
30. The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.
Malkowski MG; Martin PD; Guzik JC; Edwards BF
Protein Sci; 1997 Jul; 6(7):1438-48. PubMed ID: 9232645
[TBL] [Abstract][Full Text] [Related]
31. Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin.
Yonemura H; Imamura T; Soejima K; Nakahara Y; Morikawa W; Ushio Y; Kamachi Y; Nakatake H; Sugawara K; Nakagaki T; Nozaki C
J Biochem; 2004 May; 135(5):577-82. PubMed ID: 15173195
[TBL] [Abstract][Full Text] [Related]
32. Isolation of human blood coagulation alpha-factor Xa by soybean trypsin inhibitor-sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate.
Bock PE; Craig PA; Olson ST; Singh P
Arch Biochem Biophys; 1989 Sep; 273(2):375-88. PubMed ID: 2774557
[TBL] [Abstract][Full Text] [Related]
33. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
[TBL] [Abstract][Full Text] [Related]
34. Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin.
Bezeaud A; Drouet L; Soria C; Guillin MC
Thromb Res; 1984 Jun; 34(6):507-18. PubMed ID: 6377575
[TBL] [Abstract][Full Text] [Related]
35. Mapping of the fibrinogen-binding site on the staphylocoagulase C-terminal repeat region.
Maddur AA; Voehler M; Panizzi P; Meiler J; Bock PE; Verhamme IM
J Biol Chem; 2022 Jan; 298(1):101493. PubMed ID: 34915025
[TBL] [Abstract][Full Text] [Related]
36. Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin.
Inomoto T; Shirakami A; Kawauchi S; Shigekiyo T; Saito S; Miyoshi K; Morita T; Iwanaga S
Blood; 1987 Feb; 69(2):565-9. PubMed ID: 3801671
[TBL] [Abstract][Full Text] [Related]
37. Progressive development of a thrombin inhibitor binding site.
Hibbard LS; Nesheim ME; Mann KG
Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
[TBL] [Abstract][Full Text] [Related]
38. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.
Panizzi P; Friedrich R; Fuentes-Prior P; Kroh HK; Briggs J; Tans G; Bode W; Bock PE
J Biol Chem; 2006 Jan; 281(2):1169-78. PubMed ID: 16230340
[TBL] [Abstract][Full Text] [Related]
39. Mutations in autolytic loop-2 and at Asp554 of human prothrombin that enhance protein C activation by meizothrombin.
Koike H; Okuda D; Morita T
J Biol Chem; 2003 Apr; 278(17):15015-22. PubMed ID: 12588872
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of a prothrombin-activating protease from Nephila clavata.
Joo HS; Park GC; Cho WR; Tak E; Paik SR; Chang CS
Toxicon; 2002 Mar; 40(3):289-96. PubMed ID: 11711126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
